Antimicrobial Resistance

Featured

  • MRSA bacteria or superbug bacteria

    Commentary

    Europe's Fight Against Antimicrobial Resistance

    Nov 3, 2016

    The EC's AMR Action Plan included measures to ensure antimicrobials are used more appropriately in both humans and animals and measures to stimulate R&D of new antibiotics. One area that was not sufficiently covered was the environment.

  • Syringe and vaccine medicine

    Report

    The Economic Costs of Antimicrobial Resistance

    Dec 11, 2014

    More and more bacterial and viral infections are resistant to antimicrobial drugs. But no new classes of antibiotics have entered the market for more than 25 years. Researchers estimate that failing to address this issue will mean a lower world population in 2050 than expected and at least $2 trillion in lost global GDP.

Explore Antimicrobial Resistance

  • News Release

    News Release

    More Support for Individual Member States Is Needed to Tackle AMR in Europe

    An evaluation of the European Commission's Action Plan against antimicrobial resistance (AMR) has shown that individual member states need more help with developing and implementing their own action plans. A one-size-fits-all approach is insufficient when dealing with the diverse challenges in each country.

    Nov 3, 2016

  • Periodical

    Periodical

    RAND Review: March-April 2015

    This issue of RAND Review reports on American jihadists and the threat of homegrown terrorism in Europe, drug-resistant superbugs and the economic costs of antimicrobial resistance, profiling, resilient cities, and recent philanthropic gifts to RAND.

    Mar 4, 2015

  • Capsules and pills packed on white background

    Project

    Estimating the Economic Costs of Antimicrobial Resistance

    The costs of failing to tackle antimicrobial resistance (AMR) include a world population by 2050 that will be between 11 million and 444 million lower than it would otherwise be in the absence of AMR, and world GDP losses between $2.1 and $124.5 trillion.

    Dec 11, 2014

  • Content

    Content

    Catherine C. Cohen

    Policy Researcher
    Education B.A. in economics, biology, Swarthmore College; B.S. in nursing, Columbia University; Ph.D. in nursing, Columbia University

  • Content

    Content

    Gemma-Claire Ali

    Analyst
    Education M.Sc. in global mental health, London School of Hygiene & Tropical Medicine / King's College London; M.A. in geography, University of Cambridge

  • Content

    Content

    Lucy Hocking

    Analyst
    Education M.Sc. in child public health, Swansea University; B.Sc. in biomedical science, University of Reading

  • Content

    Content

    Daniela Rodriguez-Rincon

    Senior Analyst
    Education Ph.D. in medicine, University of Cambridge; M.Sc. in medical microbiology, London School of Hygiene and Tropical Medicine; B.Sc. in biology, Complutense University of Madrid

  • Topic Synonyms:
  • AMR